Institutionelle bei Abgenix

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Taunus Corporation 3,341,821 $30,611,080
JP Morgan Chase & Company 3,034,557 $27,796,542
Price (T.Rowe) Associates 2,997,269 $27,454,984
Franklin Resources, Inc 2,889,950 $26,471,942
Orbimed Advisors Inc. 2,826,500 $25,890,740
Wellington Management Company 1,963,800 $17,988,408
Deerfield Management 1,930,000 $17,678,800
Pequot Capital Management, Inc. 1,843,000 $16,881,880
FMR Corporation (Fidelity Management & Research Corp) 12,918,402 $118,332,562
Brinson Partners, Inc. 1,687,650 $15,458,874

Topliste der investierten Fonds
Fidelity Growth Company Fund 4,406,200 $40,360,792
Fidelity Aggressive Growth Fund 2,199,500 $20,147,420
Fidelity Select Portfolios - Biotechnology 1,974,100 $18,082,756
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 1,606,960 $14,719,753
Eaton Vance Global Health Portfolio 1,600,000 $14,656,000
Franklin Strategic Series-Franklin Small-Mid Cap Growth Fd 1,181,000 $10,817,960
Variable Insurance Products Fd-Growth Portfolio 1,181,842 $10,825,672
Finex Fonds Bio Spezial 1,100,000 $10,076,000
Fidelity Advisor Equity Growth Fund 1,077,000 $9,865,320
Putnam Vista Fund 1,082,500 $9,915,700